Patents by Inventor Zhongyu Wang

Zhongyu Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10138253
    Abstract: Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: November 27, 2018
    Assignee: ViiV HEALTHCARE UK (NO.5) LIMITED
    Inventors: John F. Kadow, B. Narasimhulu Naidu, Manoj Patel, Kevin Peese, Zhongyu Wang
  • Patent number: 10125148
    Abstract: The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
    Type: Grant
    Filed: February 19, 2014
    Date of Patent: November 13, 2018
    Assignee: ViiV HEALTHCARE UK (NO. 5) LIMITED
    Inventors: Timothy P. Connolly, Stanley D'Andrea, John F. Kadow, David R. Langley, B. Narasimhulu Naidu, Manoj Patel, Kevin Peese, Michael A. Walker, Zhongyu Wang, Zhizhen Barbara Zheng
  • Publication number: 20180230165
    Abstract: Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.
    Type: Application
    Filed: August 10, 2016
    Publication date: August 16, 2018
    Inventors: John F. KADOW, B. Narasimhulu NAIDU, Manoj PATEL, Kevin PEESE, Zhongyu WANG
  • Patent number: 9932356
    Abstract: The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
    Type: Grant
    Filed: February 10, 2015
    Date of Patent: April 3, 2018
    Assignee: ViiV HEALTHCARE UK (NO. 5) LIMITED
    Inventors: John F. Kadow, David R. Langley, B. Narasimhulu Naidu, Kevin Peese, Zhongyu Wang
  • Publication number: 20170302504
    Abstract: A method for processing a forwarding device fault, a device, and a controller are provided, and relate to the communications field. The method is as follows. An SNC receives a notification message sent by a first forwarding device, where the notification message includes a fault parameter of the first forwarding device, and the fault parameter includes a device identifier of the first forwarding device, a port identifier of a degraded port, and a degradation value of the port identified by the port identifier. The SNC determines, according to the device identifier and the port identifier, at least one forwarding path that passes through the port identified by the port identifier. The SNC also determines, according to the fault parameter of the first forwarding device and the fault parameters of other forwarding devices on one forwarding path, whether to update the forwarding path.
    Type: Application
    Filed: July 3, 2017
    Publication date: October 19, 2017
    Inventors: Zhongyu Wang, Peilin Yang, Wenxiong Zhu
  • Publication number: 20170300995
    Abstract: A system and method for optimizing clusters included in an app store are disclosed. The method comprises generating, by one or more proposal servers, one or more cluster proposals, wherein each of the one or more proposal servers executes a proposal algorithm, processing, by a cluster server, the one or more cluster proposals to resolve any conflicts within and across the one or more proposal servers, assigning a priority value to each of the one or more cluster proposals based on a predicted impact of the respective cluster proposal in the app store, forwarding to a review portal a predetermined amount of prioritized cluster proposals for review and approval, and publishing approved prioritized clusters proposals on the app store.
    Type: Application
    Filed: April 14, 2016
    Publication date: October 19, 2017
    Inventors: Zhongyu Wang, Chun How Tan, Hrishikesh Balkrishna Aradhye, Kara Bailey, Fei Hong, John Mentgen, Sebastian Camacho, Zhaoyan Su, Aaron Kwong Yue Lee, Xun Zhang
  • Publication number: 20170272339
    Abstract: Embodiments of the present invention disclose a method and an apparatus for detecting connectivity. An SDN device transmits a session negotiation packet to a second network element, where the session negotiation packet is used to negotiate a link between a first network element and the second network element, and the first network element is located in an SDN network; the SDN device obtains a response message returned by the second network element to determine that the link is negotiated successfully; and the SDN device transmits a heartbeat packet to the second network element, where the heartbeat packet is used to detect connectivity of the link. As can be learned, after determining that the link between the second network element and the first network element located in the SDN network is negotiated successfully, the SDN device transmits the heartbeat packet to the second network element.
    Type: Application
    Filed: June 5, 2017
    Publication date: September 21, 2017
    Inventors: Peilin Yang, Zhongyu Wang
  • Patent number: 9663536
    Abstract: The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection. Formule (I).
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: May 30, 2017
    Assignee: ViiV HEALTHCARE UK (NO.5) LIMITED
    Inventors: B. Narasimhulu Naidu, Manoj Patel, Kevin Peese, Zhongyu Wang
  • Patent number: 9655889
    Abstract: The disclosure generally relates to compounds of formula (I), including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: May 23, 2017
    Assignee: ViiV Healthcare UK (No.5) Limited
    Inventors: Kevin Peese, Zhongyu Wang, John F. Kadow, B. Narasimhulu Naidu
  • Patent number: 9580431
    Abstract: The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: February 28, 2017
    Assignee: ViiV Healthcare UK (No.5) Limited
    Inventors: B. Narasimhulu Naidu, Manoj Patel, Kevin Peese, Zhongyu Wang
  • Publication number: 20170015683
    Abstract: The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
    Type: Application
    Filed: February 10, 2015
    Publication date: January 19, 2017
    Inventors: John F. KADOW, David R. LANGLEY, B. Narasimhulu NAIDU, Kevin PEESE, Zhongyu WANG
  • Publication number: 20170008909
    Abstract: The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
    Type: Application
    Filed: February 19, 2014
    Publication date: January 12, 2017
    Inventors: Timothy P. CONNOLLY, Stanley D'ANDREA, John F. KADOW, David R. LANGLEY, B. Narasimhulu NAIDU, Manoj PATEL, Kevin PEESE, Michael A. WALKER, Zhongyu WANG, Zhizhen Barbara ZHENG
  • Patent number: 9409922
    Abstract: The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
    Type: Grant
    Filed: February 11, 2015
    Date of Patent: August 9, 2016
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kevin Peese, Zhongyu Wang, John F. Kadow, Prasanna Sivaprakasam, B. Narasimhulu Naidu
  • Patent number: 9373071
    Abstract: A multilayer wiring type dual-interface IC card antenna module includes: an electrode diaphragm layer, including an antenna and an electrode diaphragm; a clamping base layer including eight first through hole points right below eight metal contacts on the electrode diaphragm; an RFID antenna layer including an RFID antenna, a connecting contact, a first chip attaching point and a second chip attaching point; an insulation layer including eight second through hole points located right below the eight first through hole points, a third through hole point located right below the connecting contact, a fourth through hole point located right below the first chip attaching point, and a fifth through hole point located right below the second chip attaching point; and a bridge layer connected with the second chip attaching point and the connecting contact in a bridging manner. The antenna module can achieve full-automatic production.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: June 21, 2016
    Assignee: Beijing Basch Smartcard Co., Ltd.
    Inventors: Caifeng Liu, Zhongyu Wang, Qigang Lvqiu, Danning Wang
  • Publication number: 20160016960
    Abstract: The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
    Type: Application
    Filed: March 10, 2014
    Publication date: January 21, 2016
    Applicant: Bristol-Myers Squibb Company
    Inventors: B. NARASIMHULU NAIDU, MANOJ PATEL, KEVIN PEESE, ZHONGYU WANG
  • Publication number: 20160000771
    Abstract: The disclosure generally relates to compounds of formula (I), including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
    Type: Application
    Filed: March 10, 2014
    Publication date: January 7, 2016
    Inventors: KEVIN PEESE, ZHONGYU WANG, JOHN F. KADOW, B. NARASIMHULU NAIDU
  • Patent number: 9219360
    Abstract: The present disclosure provides a safe quick disconnect leakage protector, including a power supply circuit, a sampling circuit, a couple of single-pole single-throws, an on and off control circuit, and a testing circuit. The sampling circuit collects the leakage current signal between the live wire and the neutral wire and outputting the leakage current signal; the main control circuit receives the leakage current signal outputted from the sampling circuit, amplifies the leakage current signal, and outputs a grounding failure control signal when the leakage current reaches the predetermined value; the on and off control circuit receives the grounding failure control signal outputted from the main control circuit and controls the single-pole single-throw switches to disconnect the load from the external power supply according to the grounding failure control signal, thereby protecting the load and improves the safety of the leakage protection of an electrical appliance.
    Type: Grant
    Filed: August 9, 2011
    Date of Patent: December 22, 2015
    Assignee: SHENZHEN LIANGHUI TECHNOLOGY CO., LTD.
    Inventor: Zhongyu Wang
  • Patent number: 9206316
    Abstract: Disclosed is a thermoplastic elastomer composition comprising (i) about 10-60 wt % of at least one aliphatic polyamide; (ii) about 0.8-15 wt % of at least one graft-modified ethylene-olefin elastomeric copolymer; (iii) about 0.8-15 wt % of at least one graft-modified ethylene-propylene elastomeric copolymer, and (iv) about 35-85 wt % of at least one polyether-ester-amide block copolymer having a shore D of about 50-60 (as measured in accordance with ASTM D2240), with the total wt % of all components in the composition totaling to 100 wt %. Further disclosed herein is an article made from the thermoplastic elastomer composition disclosed above.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: December 8, 2015
    Assignee: E I DU PONT DE NEMOURS AND COMPANY
    Inventors: David D Zhang, Zhongyu Wang
  • Publication number: 20150232480
    Abstract: The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
    Type: Application
    Filed: February 11, 2015
    Publication date: August 20, 2015
    Inventors: Kevin Peese, Zhongyu Wang, John F. Kadow, Prasanna Sivaprakasam, B. Narasimhulu Naidu
  • Publication number: 20150161502
    Abstract: Disclosed is a multilayer wiring type double-interface IC card antenna module, comprising: an electrode diaphragm layer (1), a clamping base layer (2), an RFID antenna layer (3), an insulation layer (4) and a bridge layer (5). The electrode diaphragm layer (1) comprises an antenna and an electrode diaphragm. The clamping base layer (2) is arranged below the electrode diaphragm layer (1), and comprises eight first through hole points (21) located right below eight metal contacts on the electrode diaphragm. The MID antenna layer (3) is arranged below the clamping base layer (2), and comprises an RFID antenna, a connecting contact, a first chip attaching point and a second chip attaching point, the connecting contact and the first chip attaching point being connected to two ends of the RFID antenna.
    Type: Application
    Filed: June 28, 2013
    Publication date: June 11, 2015
    Applicant: Beijing Basch Smartcard Co., Ltd.
    Inventors: Caifeng Liu, Zhongyu Wang, Qigang Lvqiu, Danning Wang